Taro Pharmaceuticals, Inc.
FDA Regulatory Profile
Taro Pharmaceuticals, Inc. appears in FDA public data with 4 recalls, 1 510(k) clearance, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0089-2024, Class III) was initiated on November 6, 2023. Its most recent 510(k) clearance was granted on June 12, 1987.
Summary
- Total Recalls
- 4
- 510(k) Clearances
- 1
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|
| D-0089-2024 | Class III | Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, Mfd. by: Taro | November 6, 2023 |
| D-0116-2017 | Class II | Desoximetasone Cream USP, 0.25% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc. Brampton, Ontario, | September 13, 2016 |
| D-0117-2017 | Class II | Desoximetasone Cream USP, 0.05% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc. Brampton, Ontario, | September 13, 2016 |
| D-1370-2015 | Class III | Topicort (desoximetasone) Topical Spray, 0.25%, 100 mL Bottles, Rx Only. Mfd by: Taro Pharmaceutical | August 5, 2015 |
Recent 510(k) Clearances
| K-Number | Device | Date |
|---|
| K872128 | K-GEL | June 12, 1987 |